NO20043947L - Kombinasjoner av en alfa-2-deltaligand med en selektiv inhibitor av cyklooksygenase-2 - Google Patents

Kombinasjoner av en alfa-2-deltaligand med en selektiv inhibitor av cyklooksygenase-2

Info

Publication number
NO20043947L
NO20043947L NO20043947A NO20043947A NO20043947L NO 20043947 L NO20043947 L NO 20043947L NO 20043947 A NO20043947 A NO 20043947A NO 20043947 A NO20043947 A NO 20043947A NO 20043947 L NO20043947 L NO 20043947L
Authority
NO
Norway
Prior art keywords
cyclooxygenase
alpha
combinations
selective inhibitor
delta ligand
Prior art date
Application number
NO20043947A
Other languages
English (en)
Norwegian (no)
Inventor
Jr Charles Price Taylor
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20043947L publication Critical patent/NO20043947L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245Oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20043947A 2002-02-22 2004-09-21 Kombinasjoner av en alfa-2-deltaligand med en selektiv inhibitor av cyklooksygenase-2 NO20043947L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35929502P 2002-02-22 2002-02-22
US40436502P 2002-08-19 2002-08-19
PCT/IB2003/000534 WO2003070237A1 (en) 2002-02-22 2003-02-12 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2

Publications (1)

Publication Number Publication Date
NO20043947L true NO20043947L (no) 2004-09-21

Family

ID=27760521

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043947A NO20043947L (no) 2002-02-22 2004-09-21 Kombinasjoner av en alfa-2-deltaligand med en selektiv inhibitor av cyklooksygenase-2

Country Status (21)

Country Link
US (1) US20030199567A1 (ja)
EP (1) EP1480639A1 (ja)
JP (1) JP2005523281A (ja)
KR (1) KR20040085216A (ja)
CN (1) CN1635887A (ja)
AR (1) AR038531A1 (ja)
AU (1) AU2003246864A1 (ja)
BR (1) BR0307906A (ja)
CA (1) CA2476438A1 (ja)
CO (1) CO5611109A2 (ja)
HN (1) HN2003000071A (ja)
IL (1) IL162932A0 (ja)
MX (1) MXPA04008175A (ja)
NO (1) NO20043947L (ja)
PA (1) PA8567201A1 (ja)
PE (1) PE20031052A1 (ja)
PL (1) PL372210A1 (ja)
RU (1) RU2286151C2 (ja)
TW (1) TW200303214A (ja)
UY (1) UY27675A1 (ja)
WO (1) WO2003070237A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006511606A (ja) * 2002-12-13 2006-04-06 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 下部尿路症状を治療するα−2−δリガンド
DE602004003172T2 (de) * 2003-03-21 2007-09-27 Dynogen Pharmaceuticals Inc., Waltham Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals
WO2004084881A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
WO2004084880A1 (en) * 2003-03-21 2004-10-07 Dynogen Pharmaceuticals, Inc. METHODS FOR TREATING PAIN USING SMOOTH MUSCLE MODULATORS AND α2δ SUBUNIT CALCIUM CHANNEL MODULATORS
US7169812B2 (en) * 2003-07-01 2007-01-30 Medtronic, Inc. Process for producing injectable gabapentin compositions
AU2004271800A1 (en) * 2003-09-12 2005-03-24 Pfizer Inc. Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
GB0322140D0 (en) * 2003-09-22 2003-10-22 Pfizer Ltd Combinations
EP1682149B1 (en) * 2003-10-23 2009-12-02 Medtronic, Inc. Injectable gabapentin compositions
AU2007236115A1 (en) * 2006-04-11 2007-10-18 Novartis Ag Organic compounds
KR20090096636A (ko) * 2006-12-22 2009-09-11 노파르티스 아게 Ddp-iv 억제제로서의 1-아미노메틸-l-페닐-시클로헥산 유도체
CA2723358A1 (en) * 2008-05-05 2009-11-12 Allison B. Reiss Method for improving cardiovascular risk profile of cox inhibitors
KR101730924B1 (ko) * 2008-09-05 2017-04-27 그뤼넨탈 게엠베하 3-(3-디메틸아미노-1-에틸-2-메틸-프로필)-페놀과 항간질제의 약제학적 병용물
KR102631399B1 (ko) 2018-03-30 2024-02-01 씨지인바이츠 주식회사 폴마콕시브 및 프레가발린을 포함하는 통증 치료용 약제학적 조성물
US20220125773A1 (en) * 2020-10-28 2022-04-28 Tremeau Pharmaceuticals, Inc. Aqueous formulations of water insoluble cox-2 inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234929A (en) * 1992-07-20 1993-08-10 William Chelen Method of treating motion sickness with anticonvulsants and antitussive agents
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
US5420270A (en) * 1993-10-07 1995-05-30 G. D. Searle & Co. Aryl substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
US5352638A (en) * 1994-02-22 1994-10-04 Corning Incorporated Nickel aluminosilicate glass-ceramics
US5633272A (en) * 1995-02-13 1997-05-27 Talley; John J. Substituted isoxazoles for the treatment of inflammation
AU8668598A (en) * 1997-08-20 1999-03-08 University Of Oklahoma, The Gaba analogs to prevent and treat gastrointestinal damage
NZ502671A (en) * 1997-09-08 2003-01-31 Warner Lambert Co Combination of an analgesic with anti-epileptic properties and a NSAID
US6545022B1 (en) * 1997-12-16 2003-04-08 Pfizer Inc. 4(3)substituted-4(3)-aminomethyl-(thio)pyran or piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
EP1161263A1 (en) * 1999-03-10 2001-12-12 Warner-Lambert Company Llc Analgesic compositions comprising anti-epileptic compounds and methods of using same
HN2000000224A (es) * 1999-10-20 2001-04-11 Warner Lambert Co Aminoacidos biciclicos como agentes farmaceuticos
GB9927844D0 (en) * 1999-11-26 2000-01-26 Glaxo Group Ltd Chemical compounds
CA2362816C (en) * 1999-12-08 2007-02-06 Pharmacia Corporation Valdecoxib compositions

Also Published As

Publication number Publication date
IL162932A0 (en) 2005-11-20
UY27675A1 (es) 2003-09-30
MXPA04008175A (es) 2004-11-26
WO2003070237A1 (en) 2003-08-28
CO5611109A2 (es) 2006-02-28
CN1635887A (zh) 2005-07-06
RU2004125609A (ru) 2006-01-27
HN2003000071A (es) 2003-11-24
PA8567201A1 (es) 2003-11-12
BR0307906A (pt) 2004-12-21
PE20031052A1 (es) 2003-12-24
TW200303214A (en) 2003-09-01
JP2005523281A (ja) 2005-08-04
RU2286151C2 (ru) 2006-10-27
US20030199567A1 (en) 2003-10-23
EP1480639A1 (en) 2004-12-01
KR20040085216A (ko) 2004-10-07
AU2003246864A1 (en) 2003-09-09
PL372210A1 (en) 2005-07-11
AR038531A1 (es) 2005-01-19
CA2476438A1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
DE60319430D1 (de) R- und fgfr-inhibitoren
NO20043947L (no) Kombinasjoner av en alfa-2-deltaligand med en selektiv inhibitor av cyklooksygenase-2
HK1080069A1 (zh) 環氧酶2-抑制劑的硝酰氧基衍生物
DE60302874D1 (de) Intermittierendes aerosolabgabeventil
DE602004018837D1 (de) Ptidase-iv-inhibitoren
DE502004002000D1 (de) Befestigungselement
DK1558262T3 (da) Vandoplöselige meloxicam-granulater
DE60307008D1 (de) Erweiterbare Rohrverbindung
DK1501804T3 (da) Isoquinolinderivat MAO-B-inhibitorer
FR2836186B1 (fr) Ventilateur a flux axial
IS8109A (is) Nýjar 3-dekladínósýl 9a-N-karbamóýl og 9a-N-þíókarbamóýl afleiður af 9-deoxó-9-díhýdró-9a-asa-9a-hómóerýþrómýsíni A
DE50305617D1 (de) Befestigungselement
DE60312074D1 (de) Uhr
PL373523A1 (en) Indol-2-ones as selective inhibitors of cyclooxygenase-2
DE502004006926D1 (de) Fügevorrichtung
DE60305741D1 (de) Neue halbsynthetische macrolidantibiotika der azalidreihe
DE502004008312D1 (de) Magaziniervorrichtung
DE50311350D1 (de) Zens
FR2843451B1 (fr) Fronde du type lance-pierres
DE50306342D1 (de) Befestigungsmittel
DE10219366B4 (de) Befestigungselement
NO20044068L (no) Rorledning
DE60211471D1 (de) Schweissmutter
FI20022302A (fi) Raportointimenetelmä
NO20042122L (no) Kombinasjoner som innbefatter en selektiv cyklooksygenase-2 inhibitor